Redmile Group, LLC Argenx Se Transaction History

Redmile Group, LLC

$1.53 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$334.23 - $403.65 $6.01 Million - $7.26 Million	-17,977 Reduced 12.1%	130,540 $48.6 Million
Q4 2022 Feb 14, 2023	SELL	$342.17 - $402.31 $45 Million - $52.9 Million	-131,509 Reduced 46.96%	148,517 $56.3 Million
Q3 2022 Nov 14, 2022	SELL	$343.2 - $395.75 $36.3 Million - $41.9 Million	-105,792 Reduced 27.42%	280,026 $98.9 Million
Q2 2022 Aug 15, 2022	SELL	$269.58 - $378.88 $35.1 Million - $49.3 Million	-130,125 Reduced 25.22%	385,818 $146 Million
Q1 2022 May 16, 2022	SELL	$254.45 - $351.06 $1.45 Million - $2 Million	-5,700 Reduced 1.09%	515,943 $163 Million
Q4 2021 Feb 14, 2022	SELL	$272.01 - $353.03 $56.8 Million - $73.8 Million	-208,939 Reduced 28.6%	521,643 $183 Million
Q3 2021 Nov 15, 2021	SELL	$295.0 - $350.58 $17.6 Million - $20.9 Million	-59,700 Reduced 7.55%	730,582 $221 Million
Q2 2021 Aug 16, 2021	SELL	$257.11 - $319.92 $15.3 Million - $19.1 Million	-59,563 Reduced 7.01%	790,282 $238 Million
Q1 2021 May 17, 2021	SELL	$268.3 - $380.31 $18.4 Million - $26 Million	-68,462 Reduced 7.46%	849,845 $234 Million
Q4 2020 Feb 16, 2021	SELL	$248.13 - $308.36 $17.4 Million - $21.6 Million	-70,161 Reduced 7.1%	918,307 $270 Million
Q3 2020 Nov 16, 2020	SELL	$215.51 - $272.51 $10 Million - $12.6 Million	-46,400 Reduced 4.48%	988,468 $259 Million
Q2 2020 Aug 14, 2020	SELL	$127.44 - $232.72 $6.02 Million - $11 Million	-47,202 Reduced 4.36%	1,034,868 $233 Million
Q1 2020 May 15, 2020	SELL	$108.83 - $165.23 $7.74 Million - $11.8 Million	-71,162 Reduced 6.17%	1,082,070 $143 Million
Q4 2019 Feb 14, 2020	BUY	$106.59 - $164.21 $7.76 Million - $12 Million	72,800 Added 6.74%	1,153,232 $185 Million
Q3 2019 Nov 14, 2019	BUY	$113.31 - $150.51 $1.31 Million - $1.75 Million	11,600 Added 1.09%	1,080,432 $123 Million
Q2 2019 Aug 14, 2019	BUY	$115.0 - $141.58 $5.72 Million - $7.05 Million	49,771 Added 4.88%	1,068,832 $151 Million
Q1 2019 May 15, 2019	BUY	$98.85 - $134.59 $5.74 Million - $7.82 Million	58,100 Added 6.05%	1,019,061 $127 Million
Q4 2018 Feb 14, 2019	SELL	$63.81 - $109.82 $864,306 - $1.49 Million	-13,545 Reduced 1.39%	960,961 $92.3 Million
Q3 2018 Nov 14, 2018	BUY	$75.5 - $96.63 $22.7 Million - $29.1 Million	301,206 Added 44.74%	974,506 $73.9 Million
Q2 2018 Aug 14, 2018	BUY	$74.84 - $100.16 $32.5 Million - $43.5 Million	434,700 Added 182.19%	673,300 $55.8 Million
Q1 2018 May 15, 2018	BUY	$56.95 - $85.19 $2.2 Million - $3.29 Million	38,600 Added 19.3%	238,600 $0
Q4 2017 Feb 14, 2018	BUY	$22.57 - $63.56 $4.51 Million - $12.7 Million	200,000	200,000 $12.6 Million

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

Price T Rowe Associates Inc Baltimore, MD

5.82M
Shares

$3.67 Billion
0.36% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

3.51M
Shares

$2.21 Billion
2.99% of portfolio
Janus Henderson Group PLC London, X0

2.48M
Shares

$1.56 Billion
0.72% of portfolio
Capital World Investors Los Angeles, CA

1.7M
Shares

$1.07 Billion
0.15% of portfolio
Avoro Capital Advisors LLC New York, NY

1.24M
Shares

$780 Million
10.11% of portfolio

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.9B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Account